---
title: "Experience"
summary: "Career roles spanning bioinformatics leadership, platform development, and computational biology."
---

## Director of Bioinformatics Platform — Harvard Chan Bioinformatics Core (Apr 2024–present)
Boston, MA — [bioinformatics.sph.harvard.edu](https://bioinformatics.sph.harvard.edu)

- Lead and manage bioinformatics products to keep genomic, transcriptomic, and other omics analysis and visualization platforms reliable, efficient, and scalable.
- Guide and mentor bioinformaticians, fostering collaboration and innovation.
- Consult with researchers and external collaborators to align platforms with their bioinformatics needs and enable interdisciplinary projects.
- Oversee quality assurance and documentation to ensure analysis accuracy and reproducibility across pipelines and workflows.

## Director, Head of Computational Biology — NextRNA Therapeutics (May 2021–Feb 2024)
Cambridge, MA — [nextrna.com](https://nextrna.com/)

- Shaped company strategy for genomics data and sequencing assays as a member of the executive leadership team.
- Acted as the key interface across Biology, Technology, and Drug Discovery teams.
- Directed in-silico target discovery and validation, integrating NGS technologies with advanced visualizations.
- Oversaw Illumina and Nanopore sequencing, managing internal FTEs and CRO partnerships.
- Built an RNA structure and RNA–protein interaction AI engine using SHAPE-Seq and eCLIP-Seq data.
- Managed cloud infrastructure to ensure reproducibility and scalability.

## Principal Scientist, Computational Biology — Axcella Health (Sep 2020–Apr 2021)
Cambridge, MA — [axcellahealth.com](https://axcellahealth.com/)

- Led R&D pipelines and visualization platforms for multi-omics data.
- Applied machine learning to understand population stratification in pre-clinical studies.
- Built cloud bioinformatics infrastructure for reproducibility and scale.

## Senior Computational Biologist — eGenesis Bio (Sep 2019–Sep 2020)
Cambridge, MA — [egenesisbio.com](https://egenesisbio.com/)

- Managed internal NGS teams using Oxford Nanopore and Illumina platforms.
- Researched epigenetic marks to improve transgene expression with machine learning.
- Built QA/QC genomic platforms and multi-omics pipelines.
- Managed computational cloud infrastructure.

## Research Scientist — Harvard Chan School (Jun 2017–Apr 2019)
Boston, MA

- Led bioinformatics for a cross-organ fibrosis collaboration with Boehringer Ingelheim.
- Developed scalable, reproducible computational platforms and tools for NGS data (small RNA-seq, RNA-seq, ChIP-seq, WGS).
- Integrated multi-omics visualization within the bcbio-nextgen framework.

## Research Associate — Harvard Chan School (May 2014–Jun 2017)
Boston, MA

- Built tools for NGS analysis (small RNA-seq, single-cell and bulk RNA-seq, ChIP-seq, WGS) in bcbio-nextgen and Bioconductor.
- Developed visualization and integration of multi-omics data within bcbio-nextgen.

## Post-doctoral Fellow — Institute of Biotechnology and Biomedicine (Feb 2013–Apr 2014)
Barcelona, Spain

- Identified de novo transcripts associated with inversions in the HapMap population.
- Performed expression quantitative trait loci analyses of inversions in the HapMap population.

## Post-doctoral Fellow — Institute of Predictive and Personalized Medicine of Cancer (Sep 2011–Feb 2013)
Barcelona, Spain

- Characterized small RNAs in human sperm samples.
